Medexus Pharmaceuticals (PDDPF) News Today $2.14 0.00 (0.00%) As of 08/4/2023 Add Compare Share Share Headlines Stock AnalysisBuy This Stock PDDPF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Positive Growth Outlook for Medexus Pharmaceuticals Inc. Amid Strategic Expansion and Stable PerformanceFebruary 9, 2025 | tipranks.comStifel cuts Medexus Pharma stock rating to Hold, target to C$3.45February 7, 2025 | msn.comMedexus targets $100M annual revenue for GRAFAPEX within 5 years post-launchFebruary 6, 2025 | msn.comEarnings call transcript: Medexus Q3 FY2025 shows revenue growth, FDA approvalFebruary 6, 2025 | msn.comMedexus Pharmaceuticals Inc (MDP) Receives a Buy from Raymond JamesFebruary 3, 2025 | markets.businessinsider.comVentum Financial Reaffirms Their Buy Rating on Medexus Pharmaceuticals Inc (MDP)January 30, 2025 | markets.businessinsider.comMedexus Pharmaceuticals Launches Public Offering to Enhance Financial FlexibilityJanuary 27, 2025 | tipranks.comMedexus Pharma Shares Higher on FDA Approval for GrafapexJanuary 22, 2025 | marketwatch.comMedexus and medac Conclude Negotiations to Amend US Treosulfan Agreement, Setting Regulatory Milestone Amounts and Payment ScheduleDecember 2, 2024 | stockhouse.comMedexus Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (MDP)September 2, 2024 | theglobeandmail.comMedexus Pharma:Stocks Analysts Recently Upgraded on TSX (MDP)August 14, 2024 | theglobeandmail.comStifel Nicolaus Reaffirms Their Buy Rating on Medexus Pharmaceuticals Inc (MDP)August 9, 2024 | markets.businessinsider.comClosing Bell: Medexus Pharmaceuticals Inc flat on Monday (MDP)April 3, 2024 | theglobeandmail.comMedexus Pharmaceuticals Inc MEDXFJanuary 10, 2024 | morningstar.comMMedexus Pharmaceuticals Inc MDPDecember 21, 2023 | morningstar.comMMedexus Pharmaceuticals (MEDXF) Price Target Increased by 8.29% to 3.16November 1, 2023 | msn.comClosing Bell: Medexus Pharmaceuticals Inc flat on Tuesday (MDP)October 17, 2023 | theglobeandmail.comMedexus Announces Full Exercise and Closing of Over-Allotment Option in Bought-Deal Public OfferingOctober 17, 2023 | finance.yahoo.comClosing Bell: Medexus Pharmaceuticals Inc 6.0 Pct Debs flat on Wednesday (MDP-DB)October 12, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc 6.0 Pct Debs flat on Friday (MDP-DB)October 10, 2023 | theglobeandmail.comMedexus Pharmaceuticals announces C$10M offeringSeptember 6, 2023 | msn.comMedexus to Participate in Fireside Chat at SHARE Series EventAugust 4, 2023 | finance.yahoo.comStifel Nicolaus Upgrades Medexus Pharmaceuticals Inc (MDP) to BuyJune 22, 2023 | markets.businessinsider.comMorning News Call - Canada, June 20June 20, 2023 | finance.yahoo.comClosing Bell: Medexus Pharmaceuticals Inc down on Monday (MDP)May 16, 2023 | theglobeandmail.comMedexus gets TSX nod to make NCIB for convertible debenturesMay 10, 2023 | msn.comPharmaceutical Drug Delivery Market Research Findings to 2030May 9, 2023 | marketwatch.comClosing Bell: Medexus Pharmaceuticals Inc down on Friday (MDP)April 22, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc up on Monday (MDP)April 11, 2023 | theglobeandmail.comMedexus Pharma Names Michael Mueller Chairman, Forecasts Rise in 4Q RevenueApril 11, 2023 | marketwatch.comMedexus expects FY23 record revenue of $107M-$108MApril 11, 2023 | msn.comDiaphragm Valves for Pharmaceutical Process Market 2023 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2029March 20, 2023 | marketwatch.comDrug and Pharmaceuticals and Cosmetics Retail Market Foreseen To Grow Exponentially Over 2023-2029February 21, 2023 | marketwatch.comAn Overview of Anti-Counterfeit Pharmaceuticals And Cosmetics Market, Major Participants, and Prospects by 2029February 2, 2023 | marketwatch.comMiddle-aged and Elderly Health Supplements Market: 2023 [Latest Report] By Top Leading Players Analysis Till 2028January 31, 2023 | marketwatch.comOral Mucositis Market with Strong Focus on Industry Size, by Financial Highlights, Market Segments, Growth Rate, Revenue, and Forecast to 2029January 31, 2023 | marketwatch.comPeptide Therapy Industry by 360 Market Updates with, New Companies, Major Strategies, Massive Strategies And Forecast 2028January 30, 2023 | marketwatch.comWhy Lipella Pharmaceuticals Stock Is Soaring TodayJanuary 13, 2023 | benzinga.comMedexus sees over a year's delay for medac to provide data requested by FDA for treosulfanJanuary 12, 2023 | msn.comRare Disease Drug Market: The Adoption to Innovative Industry, Track Emerging Trends with Scoop on Economic ForcesJanuary 12, 2023 | marketwatch.comPharmaceutical Testing Market 2023 Report Focuses on Top Companys Research Methodology, Drivers and Opportunities | 108 Pages ReportJanuary 12, 2023 | marketwatch.comAnti-Counterfeit Pharmaceuticals And Cosmetics Forecast for 2028, Market 2023, Global Industry Trends, Share, Size, Growth, Analysis, DemandJanuary 11, 2023 | marketwatch.comPet Pharmaceuticals Market 2023 : Business Scenario, Corporate Profiles, Size and Dynamic Innovation by 2028January 11, 2023 | marketwatch.comAntiplatelet Drugs Market 2023 Expected to Witness the Highest Revenue Growth Over Forecast to 2028January 10, 2023 | marketwatch.comContract Research Organization (CRO) and CDMO for Pharmaceutical Market 2023 Expected to Reach Significant Rate by 2029January 10, 2023 | marketwatch.comOxaprozin Active Pharmaceutical Ingredients Market (New Report) to Eyewitness Massive Growth 2023 to 2028 | 104 Pages ReportJanuary 10, 2023 | marketwatch.comDiaphragm Valves for Pharmaceutical Process Market Size in 2023 | Growth Analysis, Key Players, Share, Revenue, Trends | Regional Forecast till 2028January 10, 2023 | marketwatch.comIncretin-Based Drugs Market Detailed Analysis of Current Industry Figures with Forecasts Regional Outlook 2028January 10, 2023 | marketwatch.comParathyroid Hormone Market Size In 2023 : High Demand, Share, Top Countries Data, Industry Analysis by Top Players, and Forecasts to 2028January 10, 2023 | marketwatch.comPharmaceutical Vials Market 2023 : Future Trends, SWOT Analysis, Remarkable Growth, and Competitive Landscape by 2028January 7, 2023 | marketwatch.com Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PDDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address PDDPF Media Mentions By Week PDDPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PDDPF News Sentiment▼0.000.99▲Average Medical News Sentiment PDDPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PDDPF Articles This Week▼00▲PDDPF Articles Average Week Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PDDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News Today FFNTF News Today ABSCF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today AVCNF News Today BIOYF News Today CBGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PDDPF) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
